Publisert 12.08.2019

US Patent - Notice of Allowance

US patent - Notice of Allowance

August 12th 2019

USPTO has today announced a notice of allowance of additional US patent on Regenics technology.

The patent is entitled: "CELLULAR EXTRACTS"

The U.S. Patent No. 16/011,134 is a continuation of U.S. Application No. 15/131,198 submitted  June 18 2018. Granting date by the USPTO is set at November 7th 2019. Patent expiration date is November 7th, 2039.

 

For more info, please contact Henrik Lund at henrik.lund@regenics.no or mobile +47 90971219

 

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.